Diabetic cardiomyopathy is a clinical condition characterized by ventricular dysfunction that develops in many diabetic patients in the absence of coronary artery disease or hypertension. Diabetic cardiomyopathy has become a major cause of diabetes-related morbidity and mortality. Despite the importance of this complication, the underlying mechanisms of diabetic cardiomyopathy are still incompletely understood. Based on four years of our investigation, our preliminary data, and evidence from literature, we propose that basal levels of autophagy are important for protecting cardiomyocytes against hyperglycemic damage and that a reduction of autophagy in diabetes contributes to the development of cardiomyopathy. Thus, the central hypothesis of this application is that AMPK activation protects cardiac structures and improves cardiac functions by increasing cardiac autophagy in diabetic heart. We propose the following specific aims to support or refute this hypothesis:
Aim 1 is to establish the essential role of AMPK in maintaining mouse cardiac function and autophagy in diabetic hearts.
Aim 2 is to the relative contributions of AMPK-dependent autophagy verse other metabolic effects of AMPK in the beneficial effects of AMPK in diabetic hearts. The last Aim is to elucidate the signaling pathways by which AMPK mediates autophagy in vivo and in cultured cardiac myocytes with or without high glucose exposure. This multidisciplinary, integrative, and translational approach to investigate the hypothesis that AMPK is critical in diabetic cardiomyopathy is technically and conceptually innovative. The proposed studies will provide new insights into how diabetes induces cardiomyopathy via the reduction of AMPK activity and a subsequent reduction of autophagic capacity and prove that specific modulation of autophagy such as stimulation of AMPK or up-regulation of Beclin 1 might be a novel approach to prevent this important complication of disease. We believe that the outcome of our investigation will have an immediate impact in providing cardioprotection in patients with diabetes, the most common metabolic disease affecting 21 million people in the United States.

Public Health Relevance

The goal of this study is to elucidate the mechanisms underlying hyperglycemic damage to cardiac myocytes and to develop therapeutic strategies to improve cardiac function in diabetes. Multidisciplinary, integrative, and translational approaches will be employed to investigate the role of AMPK and autophage in diabetic cardiomyopathy. The proposed studies will provide new insights into how diabetes induces cardiomyopathy via the reduction of AMPK activity and a subsequent reduction of autophagic capacity and prove that specific modulation of autophagy such as stimulation of AMPK or up-regulation of Beclin 1 might be a novel approach to prevent this important complication of disease. It is our expectation that the outcomes of our investigation will have an immediate impact in providing cardioprotection in patients with diabetes. .

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL080499-06A1
Application #
8214207
Study Section
Vascular Cell and Molecular Biology Study Section (VCMB)
Program Officer
Liu, Lijuan
Project Start
2006-04-01
Project End
2016-01-31
Budget Start
2012-02-07
Budget End
2013-01-31
Support Year
6
Fiscal Year
2012
Total Cost
$479,095
Indirect Cost
$155,382
Name
University of Oklahoma Health Sciences Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
878648294
City
Oklahoma City
State
OK
Country
United States
Zip Code
73117
Duan, Quanlu; Ni, Li; Wang, Peihua et al. (2016) Deregulation of XBP1 expression contributes to myocardial vascular endothelial growth factor-A expression and angiogenesis during cardiac hypertrophy in vivo. Aging Cell 15:625-33
Okon, Imoh S; Ding, Ye; Coughlan, Kathleen A et al. (2016) Aberrant NRP-1 expression serves as predicator of metastatic endometrial and lung cancers. Oncotarget 7:7970-8
Dai, Xiaoyan; Ding, Ye; Liu, Zhaoyu et al. (2016) Phosphorylation of CHOP (C/EBP Homologous Protein) by the AMP-Activated Protein Kinase Alpha 1 in Macrophages Promotes CHOP Degradation and Reduces Injury-Induced Neointimal Disruption In Vivo. Circ Res 119:1089-1100
Ding, Ye; Chen, Jie; Okon, Imoh Sunday et al. (2016) Absence of AMPKα2 accelerates cellular senescence via p16 induction in mouse embryonic fibroblasts. Int J Biochem Cell Biol 71:72-80
Wang, Qiongxin; Liu, Danxia; Song, Ping et al. (2015) Tryptophan-kynurenine pathway is dysregulated in inflammation, and immune activation. Front Biosci (Landmark Ed) 20:1116-43
Cai, Zhejun; Lu, Qiulun; Ding, Ye et al. (2015) Endothelial Nitric Oxide Synthase-Derived Nitric Oxide Prevents Dihydrofolate Reductase Degradation via Promoting S-Nitrosylation. Arterioscler Thromb Vasc Biol 35:2366-73
Wu, Yue; Song, Ping; Zhang, Wencheng et al. (2015) Activation of AMPKα2 in adipocytes is essential for nicotine-induced insulin resistance in vivo. Nat Med 21:373-82
Duan, Quanlu; Yang, Lei; Gong, Wei et al. (2015) MicroRNA-214 Is Upregulated in Heart Failure Patients and Suppresses XBP1-Mediated Endothelial Cells Angiogenesis. J Cell Physiol 230:1964-73
Okon, Imoh S; Zou, Ming-Hui (2015) Mitochondrial ROS and cancer drug resistance: Implications for therapy. Pharmacol Res 100:170-4
Liu, Zhaoyu; Zhang, Wencheng; Zhang, Miao et al. (2015) Liver kinase B1 suppresses lipopolysaccharide-induced nuclear factor κB (NF-κB) activation in macrophages. J Biol Chem 290:2312-20

Showing the most recent 10 out of 85 publications